RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Igor C. Almeida to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Igor C. Almeida has written about Cell Line, Tumor.
Igor C. Almeida
Connection Strength
0.043
Cell Line, Tumor
  1. Cavalcante FML, Almeida IV, D?sman E, Mantovani MS, Vicentini VEP. Cytotoxicity, mutagenicity, and antimutagenicity of the gentisic acid on HTC cells. Drug Chem Toxicol. 2018 Apr; 41(2):155-161.
    View in: PubMed
    Score: 0.020
  2. Dias BR, Rodrigues EG, Nimrichter L, Nakayasu ES, Almeida IC, Travassos LR. Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3. Mol Cancer. 2009 Dec 07; 8:116.
    View in: PubMed
    Score: 0.012
  3. Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res. 2008 Sep; 7(9):4004-12.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support